Literature DB >> 1899455

Mortality and duration of hemodialysis treatment.

P J Held1, N W Levin, R R Bovbjerg, M V Pauly, L H Diamond.   

Abstract

Decrease in the average duration of hemodialysis treatment time is a continuing phenomenon. We investigated the relationship of 3-year mortality to duration of dialysis in a 1984-1985 national random sample of 600 hemodialysis patients from 36 dialysis units. Mortality was negatively associated with duration of dialysis treatments, as shown by the Cox model, adjusted for other patient and dialysis unit covariates. With adjustment for other covariates, patients receiving an average dialysis treatment duration of less than 3.5 hours had relative mortality risks of 1.17 to 2.18 compared with those with treatments longer than 3.5 hours (mortality risk of 1.0). Reverse causation (the possibility that more seriously ill patients received dialysis for a shorter time) appears unlikely. We conclude that duration of the dialysis procedure is an important element in determining patient mortality as one of the factors determining the adequacy of dialysis.

Entities:  

Mesh:

Year:  1991        PMID: 1899455

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  22 in total

1.  GigaPoPs, teraflops and haptics: new medicines for the new millennium?

Authors:  J F Winchester
Journal:  Trans Am Clin Climatol Assoc       Date:  2000

2.  Effect of dialysis center profit-status on patient survival: a comparison of risk-adjustment and instrumental variable approaches.

Authors:  John M Brooks; Christopher P Irwin; Lawrence G Hunsicker; Michael J Flanigan; Elizabeth A Chrischilles; Jane F Pendergast
Journal:  Health Serv Res       Date:  2006-12       Impact factor: 3.402

3.  Cost-effectiveness of frequent in-center hemodialysis.

Authors:  Chris P Lee; Stefanos A Zenios; Glenn M Chertow
Journal:  J Am Soc Nephrol       Date:  2008-07-09       Impact factor: 10.121

Review 4.  Controversies in determination of epoetin (recombinant human erythropoietin) dosages.

Authors:  P A Abraham; W L St Peter; K A Redic-Kill; C E Halstenson
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

5.  Longer dialysis session length is associated with better intermediate outcomes and survival among patients on in-center three times per week hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  Francesca Tentori; Jinyao Zhang; Yun Li; Angelo Karaboyas; Peter Kerr; Rajiv Saran; Juergen Bommer; Friedrich Port; Takashi Akiba; Ronald Pisoni; Bruce Robinson
Journal:  Nephrol Dial Transplant       Date:  2012-03-19       Impact factor: 5.992

6.  Renal Association Clinical Practice Guideline on Haemodialysis.

Authors:  Damien Ashby; Natalie Borman; James Burton; Richard Corbett; Andrew Davenport; Ken Farrington; Katey Flowers; James Fotheringham; R N Andrea Fox; Gail Franklin; Claire Gardiner; R N Martin Gerrish; Sharlene Greenwood; Daljit Hothi; Abdul Khares; Pelagia Koufaki; Jeremy Levy; Elizabeth Lindley; Jamie Macdonald; Bruno Mafrici; Andrew Mooney; James Tattersall; Kay Tyerman; Enric Villar; Martin Wilkie
Journal:  BMC Nephrol       Date:  2019-10-17       Impact factor: 2.388

Review 7.  On-line monitoring of the delivery of the hemodialysis prescription.

Authors:  P R Keshaviah; J P Ebben; P F Emerson
Journal:  Pediatr Nephrol       Date:  1995       Impact factor: 3.714

Review 8.  Nephrology, dialysis and transplantation.

Authors:  K Farrington; P Sweny
Journal:  Postgrad Med J       Date:  1993-07       Impact factor: 2.401

9.  Shorter delivered dialysis times associate with a higher and more difficult to treat blood pressure.

Authors:  Teena Tandon; Arjun D Sinha; Rajiv Agarwal
Journal:  Nephrol Dial Transplant       Date:  2013-01-24       Impact factor: 5.992

Review 10.  The advantages and challenges of increasing the duration and frequency of maintenance dialysis sessions.

Authors:  Charles Chazot; Guillaume Jean
Journal:  Nat Clin Pract Nephrol       Date:  2008-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.